España
India
Italia
대한민êµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Dyadic International
DYAI
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Dyadic International (DYAI) Forecast
News
Earnings
Dyadic International (DYAI) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Dyadic International (NASDAQ:DYAI) Stock
Dyadic International Stock (NASDAQ: DYAI)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, January 13, 2025
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Thursday, November 21, 2024
Dyadic Receives $3M Grant From Gates Foundati...
Benzinga Newsdesk
Thursday, November 14, 2024
HC Wainwright & Co. Reiterates Buy on Dyadic ...
Benzinga Newsdesk
Tuesday, November 12, 2024
Dyadic International Q3 2024 GAAP EPS $(0.01)...
Benzinga Newsdesk
Earnings Scheduled For November 12, 2024
Benzinga Insights
Monday, November 11, 2024
Exploring Dyadic International's Earnings Expectations
Benzinga Insights
Monday, September 23, 2024
Dyadic Provides Update On Business Progress A...
Benzinga Newsdesk
Tuesday, August 13, 2024
Dyadic International Q2 2024 GAAP EPS $(0.07)...
Benzinga Newsdesk
Monday, July 08, 2024
HC Wainwright & Co. Reiterates Buy on Dyadic ...
Benzinga Newsdesk
Monday, July 01, 2024
Watching Dyadic International; Zacks Small-Ca...
Benzinga Newsdesk
Friday, June 28, 2024
Dyadic International And Proliant Health And ...
Benzinga Newsdesk
Tuesday, May 14, 2024
Dyadic International Q1 EPS $(0.07) Down From...
Benzinga Newsdesk
Thursday, March 28, 2024
Recap: Dyadic International Q4 Earnings
Benzinga Insights
Dyadic International Q4 EPS $(0.08) Misses $(...
Benzinga Newsdesk
Dyadic International Appoints Patrick Lucy As...
Benzinga Newsdesk
Earnings Scheduled For March 28, 2024
Benzinga Insights
Wednesday, March 27, 2024
Dyadic International's Earnings: A Preview
Benzinga Insights
Tuesday, March 26, 2024
Dyadic Publishes C1 Monoclonal Antibody In No...
Benzinga Newsdesk
Monday, March 11, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Wednesday, February 28, 2024
Dyadic Announces Strategic Partnership Agreem...
Benzinga Newsdesk
Wednesday, February 21, 2024
Dyadic Advances Collaboration With Israel Ins...
Benzinga Newsdesk
Monday, February 19, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Friday, February 16, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Tuesday, February 13, 2024
Dyadic And Cygnus Technologies Partner; Cygnu...
Benzinga Newsdesk
Tuesday, February 06, 2024
Dyadic Announces Research And Development Col...
Benzinga Newsdesk
Wednesday, November 29, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Dyadic Announces Top-Line Results From Its Su...
Benzinga Newsdesk
Monday, November 13, 2023
HC Wainwright & Co. Reiterates Buy on Dyadic ...
Benzinga Newsdesk
Wednesday, November 08, 2023
Recap: Dyadic International Q3 Earnings
Benzinga Insights
Dyadic International Q3 2023 EPS $(0.06) Beat...
Benzinga Newsdesk
Earnings Scheduled For November 8, 2023
Benzinga Insights
Friday, October 06, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
On Oct 2, Janssen Provided Written Notice To ...
Benzinga Newsdesk
Thursday, October 05, 2023
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Dyadic's C1 Platform Selected By The Vaccine ...
Benzinga Newsdesk
Tuesday, September 26, 2023
Dyadic International And Byorna Have Entered ...
Benzinga Newsdesk
Tuesday, September 19, 2023
Dyadic Announces A Development, Exclusive Lic...
Benzinga Newsdesk
Wednesday, August 09, 2023
Dyadic International Q2 EPS $(0.07) Misses $(...
Benzinga Newsdesk
Earnings Scheduled For August 9, 2023
Benzinga Insights
Monday, August 07, 2023
Dyadic Announces Results From Third Party Ana...
Benzinga Newsdesk
Monday, July 24, 2023
Dyadic Provides Phase 1 Clinical Trial Update...
Benzinga Newsdesk
Wednesday, June 21, 2023
Dyadic Announced An MoU With Bangladesh's State-Owned Pharmaceutical Company To Facilitate Biopharmaceutical Research And Biomanufacturing Capacity
Happy Mohamed
Wednesday, May 24, 2023
HC Wainwright & Co. Reiterates Buy on Dyadic ...
Benzinga Newsdesk
Wednesday, May 10, 2023
Dyadic International Q1 EPS $(0.03) Up From $...
Benzinga Newsdesk
Earnings Scheduled For May 10, 2023
Benzinga Insights
Monday, May 08, 2023
Dyadic Announces Collaboration To Commercialize Animal-Free Alternative Proteins Using Dapibus
Happy Mohamed
Tuesday, April 18, 2023
Dyadic Receives US Patent For Manufacturing S...
Benzinga Newsdesk
Friday, April 14, 2023
Dyadic International Has Received A Notice Of Allowance For Its U.S. Patent Application 16/640,483 Titled "Production Of Flu Vaccine In Myceliophthora Thermophila"
Happy Mohamed
Wednesday, April 12, 2023
Dyadic Signed An Expanded Licensing Agreement...
Benzinga Newsdesk
Thursday, March 30, 2023
Watching Dyadic International; Zacks Small-Cap Research Sets $9 Price Valuation
Happy Mohamed
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
